Krystal Biotech expects EMA opinion on DEB therapy in 1Q 2025

4 months ago

PITTSBURGH - Krystal Biotech , Inc. (NASDAQ: NASDAQ:KRYS), a commercial-stage biotechnology firm with a market capitalization of $5.3 billion and…

Planet Labs inventory tumbles on income miss and weak steering

4 months ago

SAN FRANCISCO - Planet Labs PBC reported third-quarter earnings that beat analyst expectations, however income fell quick and the corporate…

Factbox-Brokerages see ‘unsure’ 2025 on worries over potential Trump tariffs

4 months ago

(Reuters) -Uncertainties round U.S. insurance policies could gradual international financial development modestly in 2025, in keeping with main brokerages. They…

Hungary’s Viktor Orban meets Trump, Musk at Mar-a-Lago

4 months ago

(Reuters) - Hungarian Prime Minister Viktor Orban met with Donald Trump and billionaire Elon Musk on the U.S. president-elect's Mar-a-Lago…

MapmyIndia retains shopper enterprise, shares soar

4 months ago

CE Information Techniques Ltd., which operates underneath the model title MapmyIndia, has determined to not proceed with its beforehand introduced…

Cardano Falls 10% In Rout

4 months ago

Investing.com - Cardano was buying and selling at $1.0589 by 15:48 (20:48 GMT) on the Investing.com Index on Monday, down…

Roblox CFO Michael Guthrie sells $5.59 million in inventory

4 months ago

Along with the gross sales, Guthrie exercised choices to amass 100,000 shares at a value of $0.53 per share, totaling…

Eli Lilly units new $15 billion share buyback, raises dividend

4 months ago

INDIANAPOLIS - Eli Lilly and Firm (NYSE: NYSE:LLY), with its spectacular market capitalization of $722 billion, in the present day…

Yext shares tumble 10% on earnings miss regardless of income beat

4 months ago

NEW YORK - Yext, Inc. (NYSE: NYSE:YEXT) shares fell sharply, by 10.1% in after-hours buying and selling on Monday after…

Third Harmonic Bio's SWOT evaluation: oral KIT inhibitor inventory exhibits promise

4 months ago

Third Harmonic Bio's SWOT evaluation: oral KIT inhibitor inventory exhibits promise